Pages: 752
Publisher: Wiley-Blackwell
Year of Publication: 2016
Author(s) : Cheng Liu (Editor), K. John Morrow, Jr.
Book Description:
Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing.
• Guides readers through the complex landscape involved with developing biosimilar versions of monoclonal antibody (mAb) drugs
• Features flow charts, tables, and figures that clearly illustrate processes and makes the book comprehensible and accessible
• Includes a review of FDA-approved mAb drugs as a quick reference to facts and useful information
• Examines new technologies and strategies for improving biosimilar mAbs
http://as.wiley.com/WileyCDA/WileyTitle/productCd-1118662318.html